Escin attenuates osteoarthritis via suppressing fibroblast-like synoviocytes Jun–promoted synovial inflammation and osteoclast differentiation
Bone · 2026
DOI: 10.1016/j.bone.2026.118091 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bone, 2026. Verfasst von Yue Yuan und 15 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Medicinal Resources and Natural Pharmaceutical Chemistry, Ministry of Education, College of Life Sciences, Shaanxi Normal Universi…. Hauptthemen laut MEDLINE: Osteoarthritis, Cell Differentiation, Synoviocytes, Osteoclasts. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: Shaanxi Province Key Research and Development Projects, Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Osteoarthritis (OA) is a chronic, age-related disease that severely impairs the quality of life. The pathogenesis of OA remains unknown, and current pharmacological treatments are still limited. Thus, it is urgent to identify disease targets and develop more effective therapeutic agents for OA. METHODS: miR-590-3p expression in synovial tissues, fibroblast-like synoviocytes (FLS) and sera of OA patients was detected using miRNA microarray, fluorescence in situ hybridization (FISH), qPCR, and bioinformatics. Luciferase reporter assays and Western blot were employed to confirm the transcriptional regulator of miR-590-3p, proto-oncogene Jun (JUN), and its target genes. Virtual screening, molecular dynamics simulation, and thermal mobility shift assay were performed to screen inhibitors of JUN. The efficacy of escin on OA was verified by constructing a mice model of OA. RESULTS: miR-590-3p was downregulated in the synovium and plasma of OA patients by IL-1β. Mechanistically, OA FLS miR-590-3p expression was regulated by IL-1β/JNK/JUN axis, and was extensively involved in IL-1β-triggered inflammation and osteoclastogenesis through specifically targeting Dickkopf-related protein 1 (DKK1) and receptor activator of nuclear factor-kB Ligand (RANKL). JUN was upregulated in OA synovium and plasma, and located in a hub position of this axis to mediate OA progression. Escin was identified as a targeted inhibitor of JUN, which significantly attenuated OA FLS-mediated inflammation and osteoclast differentiation both in vitro and in vivo via restoring the IL-1β/JUN/miR-590/DKK-1/RANKL axis to normal level. CONCLUSIONS: Our study determined that escin inhibits synovial inflammation and bone destruction in OA by directly targeting JUN, leading to the turnover of miR-590-3p and the repression of DKK1 and RANKL. These findings suggest that escin could serve as a promising therapeutic agent for the treatment of OA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory for Medicinal Resources and Natural Pharmaceutical Chemistry, Ministry of Education, College of Life Sciences, Shaanxi Normal University, Xi'an, 710119, China; Laboratory of Neurological Diseases and Brai…
- Department of Orthopedics, Xijing Hospital, Air Force Medical University, Xi'an, 710000, China.
- Key Laboratory for Medicinal Resources and Natural Pharmaceutical Chemistry, Ministry of Education, College of Life Sciences, Shaanxi Normal University, Xi'an, 710119, China.
- Department of Laboratory Pathology, Xijing 986 Hospital Department, Air Force Medical University, Xi'an, 710000, China.
- Department of Neurology, Zhongshan Hospital Fudan University, Shanghai, 200032, China.
- Department of Neurology, Xijing 986 Hospital Department, Air Force Medical University, Xi'an, 710000, China.
Förderung
- Shaanxi Province Key Research and Development Projects
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- Fundamental Research Funds for Central Universities of the Central South University
Zitieren
APA
Yuan, Y., Sun, Q., Hui, T., Liu, Y., Li, Y., Wang, G., Wang, C., Feng, G., Wang, J., Wang, Z., Kang, J., Yan, Y., Wang, L., Liu, Y., Xue, X., & Zhang, D. (2026). Escin attenuates osteoarthritis via suppressing fibroblast-like synoviocytes Jun–promoted synovial inflammation and osteoclast differentiation. Bone. https://doi.org/10.1016/j.bone.2026.118091
Vancouver
Yuan Y, Sun Q, Hui T, Liu Y, Li Y, Wang G, et al. Escin attenuates osteoarthritis via suppressing fibroblast-like synoviocytes Jun–promoted synovial inflammation and osteoclast differentiation. Bone. 2026. doi:10.1016/j.bone.2026.118091
BibTeX
@article{Yuan2026,
author = {Yuan, Yue and Sun, Qiang and Hui, Teng and Liu, Yiran and Li, Yan and Wang, Gan and Wang, Changli and Feng, Guodong and Wang, Jing and Wang, Zenglu and Kang, Jiefang and Yan, Yaping and Wang, Lei and Liu, Yan and Xue, Xiaochang and Zhang, Dawei},
title = {Escin attenuates osteoarthritis via suppressing fibroblast-like synoviocytes Jun–promoted synovial inflammation and osteoclast differentiation},
journal = {Bone},
year = {2026},
doi = {10.1016/j.bone.2026.118091}
}
EUVIMED